Molecular updates in adipocytic neoplasms✰.
Adipocytic neoplasms include a diversity of both benign tumors (lipomas) and malignancies (liposarcomas), and each tumor type is characterized by its own unique molecular alterations driving tumorigenesis. Work over the past 30 years has established the diagnostic utility of several of these characteristic molecular alterations (e.g. MDM2 amplification in well- and dedifferentiated liposarcoma, FUS/EWSR1-DDIT3 gene fusions in myxoid liposarcoma, RB1 loss in spindle cell/pleomorphic lipoma). More recent studies have focused on additional molecular alterations which may have therapeutic or prognostic impact. This review will summarize several of the important molecular findings in adipocytic tumors that have been described over the past 10 years.
['Demicco|Elizabeth G|EG|']
D014408:Biomarkers, Tumor D006801:Humans D018205:Neoplasms, Adipose Tissue
MDM2 Dedifferentiated liposarcoma Myxoid liposarcoma RB1 Atypical spindle cell lipomatous tumor CDK4 Genomics TERT Well-differentiated liposarcoma